Cargando…

Cellular infiltrate in cutaneous leishmaniasis lesions and therapeutic outcome()()

BACKGROUND: The treatment of cutaneous leishmaniasis is a challenge. A better understanding of the in situ mechanisms involved in the evolution and cure of the disease is essential for the development of new therapies. OBJECTIVE: Correlate histopathological and immunological characteristics of cutan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ribeiro, Camila Sampaio, França, Riam Rocha, Silva, Juliana Almeida, Silva, Silvana Conceição da, Uliana, Sílvia R.B., Boaventura, Viviane Sampaio, Machado, Paulo R.L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Dermatologia 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441461/ https://www.ncbi.nlm.nih.gov/pubmed/34330599 http://dx.doi.org/10.1016/j.abd.2021.02.006

Ejemplares similares

Recurrent cutaneous leishmaniasis*
por: Gomes, Ciro Martins, et al.
Publicado: (2013)

Proteome Profiling of Human Cutaneous Leishmaniasis Lesion
por: da Silva Santos, Claire, et al.
Publicado: (2015)

Diabetes Modifies the Clinic Presentation of Cutaneous Leishmaniasis
por: Lago, Alexsandro S, et al.
Publicado: (2020)

Transcriptome Analysis Identifies the Crosstalk between Dendritic and Natural Killer Cells in Human Cutaneous Leishmaniasis
por: Nunes, Sara, et al.
Publicado: (2023)

Comparison of cardiotoxicity between N-methyl-glucamine and miltefosine in the treatment of American cutaneous leishmaniasis()()
por: Barroso, Daniel Holanda, et al.
Publicado: (2021)

Systems Approach Reveals Nuclear Factor Erythroid 2-Related Factor 2/Protein Kinase R Crosstalk in Human Cutaneous Leishmaniasis
por: Vivarini, Áislan de Carvalho, et al.
Publicado: (2017)

Atypical Manifestations of Cutaneous Leishmaniasis in a Region Endemic for Leishmania braziliensis: Clinical, Immunological and Parasitological Aspects
por: Guimarães, Luiz Henrique, et al.
Publicado: (2016)

Exuberant case of verrucous cutaneous leishmaniasis()
por: Novaes, Jana Regis, et al.
Publicado: (2022)

Successful treatment of diffuse cutaneous leishmaniasis caused by Leishmania amazonensis()()
por: Sampaio, Raimunda Nonata Ribeiro, et al.
Publicado: (2021)

RISK FACTORS ASSOCIATED WITH AMERICAN CUTANEOUS LEISHMANIASIS IN AN ENDEMIC AREA OF BRAZIL
por: de ARAUJO, Alberon Ribeiro, et al.
Publicado: (2016)

Towards a standard protocol for antimony intralesional infiltration technique for cutaneous leishmaniasis treatment
por: da Silva, Rosiana Estéfane, et al.
Publicado: (2018)

Multi-omic Analyses of Plasma Cytokines, Lipidomics, and Transcriptomics Distinguish Treatment Outcomes in Cutaneous Leishmaniasis
por: Malta-Santos, Hayna, et al.
Publicado: (2020)

Differential effects of antigens from L. braziliensis isolates from disseminated and cutaneous leishmaniasis on in vitro cytokine production
por: Leopoldo, Paulo TG, et al.
Publicado: (2006)

Clinical Profile and Diagnosis of Recurrent Cutaneous Leishmaniasis
por: Arruda, Sérgio, et al.
Publicado: (2023)

Integrated Analysis Reveals That miR-193b, miR-671, and TREM-1 Correlate With a Good Response to Treatment of Human Localized Cutaneous Leishmaniasis Caused by Leishmania braziliensis
por: Nunes, Sara, et al.
Publicado: (2018)

Development of Cutaneous Leishmaniasis after Leishmania Skin Test
por: Machado, Paulo R., et al.
Publicado: (2011)

CD8(+) Granzyme B(+)–Mediated Tissue Injury vs. CD4(+)IFNγ(+)–Mediated Parasite Killing in Human Cutaneous Leishmaniasis
por: Santos, Claire da Silva, et al.
Publicado: (2013)

Advances in Development of New Treatment for Leishmaniasis
por: de Menezes, Juliana Perrone Bezerra, et al.
Publicado: (2015)

Plantar ulcer as an atypical manifestation of cutaneous leishmaniasis()()
por: Tironi, Fernanda de Carvalho, et al.
Publicado: (2021)

The Role of Nitric Oxide and Reactive Oxygen Species in the Killing of Leishmania braziliensis by Monocytes from Patients with Cutaneous Leishmaniasis
por: Carneiro, Pedro Paulo, et al.
Publicado: (2016)

A Double-blind, Randomized Trial to Evaluate Miltefosine and Topical Granulocyte Macrophage Colony-stimulating Factor in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil
por: Machado, Paulo R L, et al.
Publicado: (2020)

Efficacy of Spironolactone Treatment in Murine Models of Cutaneous and Visceral Leishmaniasis
por: Andrade-Neto, Valter Viana, et al.
Publicado: (2021)

Meglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a single arm, open label, phase II clinical trial
por: Ramalho, Dario Brock, et al.
Publicado: (2018)

A dysflagellar mutant of Leishmania (Viannia) braziliensis isolated from a cutaneous leishmaniasis patient
por: Zauli, Rogéria C, et al.
Publicado: (2012)

Evaluation of the Ability of Miltefosine Associated with Topical GM-CSF in Modulating the Immune Response of Patients with Cutaneous Leishmaniasis
por: Peixoto, Fábio, et al.
Publicado: (2020)

Reactivation of cutaneous and mucocutaneous tegumentary leishmaniasis in rheumatoid arthritis patients: an emerging problem?
por: de Souza, Regina Maia, et al.
Publicado: (2017)

Cutaneous leishmaniasis mimicking cutaneous lymphoma
por: Pires, Carla Andréa Avelar, et al.
Publicado: (2019)

Accuracy of the Zika IgM Antibody Capture Enzyme-Linked Immunosorbent Assay from the Centers for Disease Control and Prevention (CDC Zika MAC-ELISA) for Diagnosis of Zika Virus Infection
por: Machado Portilho, Moyra, et al.
Publicado: (2020)

Host-Directed Therapies for Cutaneous Leishmaniasis
por: Novais, Fernanda O., et al.
Publicado: (2021)

Lutzomyia whitmani is the main vector of American Cutaneous Leishmaniasis in the Brazilian Federal District and the most prevalent species in residential areas of the Administrative Region of Sobradinho()
por: Barreto, Mariana Boff, et al.
Publicado: (2014)

Leishmania infantum AS A CAUSATIVE AGENT OF CUTANEOUS LEISHMANIASIS IN THE STATE OF MATO GROSSO DO SUL, BRAZIL
por: CASTRO, Ludiele Souza, et al.
Publicado: (2016)

Forecasting Temporal Dynamics of Cutaneous Leishmaniasis in Northeast Brazil
por: Lewnard, Joseph A., et al.
Publicado: (2014)

Comparative analysis of the tissue inflammatory response in human cutaneous and disseminated leishmaniasis
por: Dantas, Marina Loyola, et al.
Publicado: (2014)

Intralesional infiltration versus parenteral use of meglumine antimoniate for treatment of cutaneous leishmaniasis: A cost-effectiveness analysis
por: Brito, Nayara C., et al.
Publicado: (2019)

Differential expression of polyamine biosynthetic pathways in skin lesions and in plasma reveals distinct profiles in diffuse cutaneous leishmaniasis
por: Malta-Santos, Hayna, et al.
Publicado: (2020)

A retrospective cohort study of the effectiveness and adverse events of intralesional pentavalent antimonials in the treatment of cutaneous leishmaniasis
por: Rodrigues, Bruna Côrtes, et al.
Publicado: (2020)

Filter paper performance in PCR for cutaneous leishmaniasis diagnosis
por: Mota, Camila Alves, et al.
Publicado: (2020)

Characterization of Neutrophil Function in Human Cutaneous Leishmaniasis Caused by Leishmania braziliensis
por: Conceição, Jacilara, et al.
Publicado: (2016)

Miltefosine in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil: A Randomized and Controlled Trial
por: Machado, Paulo R., et al.
Publicado: (2010)

Amentoflavone as an Ally in the Treatment of Cutaneous Leishmaniasis: Analysis of Its Antioxidant/Prooxidant Mechanisms
por: Rizk, Yasmin Silva, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pf2tv83m3gim3hpsfo9mepd2e4